- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01604421
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part II
February 18, 2019 updated by: Wally Carlo, University of Alabama at Birmingham
Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part II
The overall hypothesis is that plastic bags used in combination with WHO thermoregulation care will reduce the incidence of hypothermia in preterm/low birth weight and full term infants when compared to routine WHO thermoregulation care alone.
Part II is for preterm/low birth weight infant with or without plastic head cover used from 1 hour after birth until discharge or 24 hours after birth to assist with temperature regulation.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Due to limited resources, hospitals in the developing world struggle to provide sufficient incubators and to maintain climate-controlled nurseries.
Therefore, premature low birth weight infants continue to be at an increased risk of hypothermia throughout their hospitalizations.
This study will compare the incidence of hypothermia in preterm/low birth weight infants randomized to receive WHO thermoregulation care (control groups) or WHO thermoregulation care and a plastic bag covering their torsos and lower extremities (intervention group) starting at one hour after birth and continued to discharge or 24 hours after birth, whichever occurs first.
The axillary temperature of each infant will be taken one hour after birth, every subsequent 3-4 hours, and at discharge or 24 hours after birth when infants will be removed from the plastic bags.
Seizures, hyperthermia, room temperature, and death will be recorded throughout the hospitalization for all infants.
With an estimated baseline hypothermia rate of 50% and a hypothesized 20% absolute risk reduction (40% relative risk reduction), a sample size of 182 will be used to have a power of 80% and a confidence interval of 95%.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lusaka, Zambia
- University Teaching Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 hour to 3 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Estimated gestational age 29-36 6/7 weeks or birth weight 1400-2500g
- Delivery in the hospital
Exclusion Criteria:
- Infant admitted to the NICU
- Birth weight less than 1400 gms
- Abdominal wall defect or myelomeningocele
- Major congenital anomalies
- Blistering skin disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Thermoregulation-standard care
Standard thermoregulation without a plastic bag from one hour after birth until discharge or 24 hours after birth, whichever comes first.
|
Standard care without plastic bag.
One hour after birth, a blanket will be wrapped around the infant and he/she will receive a wool hat, according to standard practices.
The infant's axillary temperature will be monitored for 24 hours or until discharge, whichever comes first.
|
Active Comparator: Thermoregulation-with plastic bag
Thermoregulation with plastic bag covering torso and lower extremities from one hour after birth until discharge or 24 hours after birth to assist with thermoregulation.
The infant's axillary temperature will be monitored for 24 hours or until discharge, whichever comes first.
|
One hour after birth, the infant will be placed into a plastic bag up to his/her axillae, and the bag will be folded and taped to itself to prevent it from covering the infant's nose or mouth.
A blanket will be wrapped around the infant, and he/she will receive a wool hat.
The infant will remain in the bag, which will be changed when soiled, for 24 hours or until discharge, whichever occurs first.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Axillary temperature < 36.5 degrees Celsius
Time Frame: Discharge or 24 hours after birth
|
Temperature taken per axilla at one hour after birth.
Temperatures 36.0-36.4 will be classified as mild hypothermia, 32.0-35.9
will be classified as moderate hypothermia, and <32.0 as severe hypothermia.
|
Discharge or 24 hours after birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory Distress Syndrome (RDS)
Time Frame: Up to 4 weeks
|
Documentation of increased work of breathing, retractions, and a need for oxygen, intubation, or surfactant
|
Up to 4 weeks
|
Pneumothorax
Time Frame: Up to 4 weeks
|
Either chest radiograph documentation or clinical deterioration consistent with air leak
|
Up to 4 weeks
|
Sepsis
Time Frame: Up to 4 weeks
|
Culture proven or culture negative clinically treated course consistent with sepsis
|
Up to 4 weeks
|
Death
Time Frame: Up to 4 weeks
|
Cardiorespiratory failure
|
Up to 4 weeks
|
Hyperthermia
Time Frame: Up to 4 weeks
|
Axillary temperature > 38 degrees Celsius per temperature taken per axilla for one minute
|
Up to 4 weeks
|
Temperature and humidity
Time Frame: 1-72 hours after birth
|
A recording of the room temperature and humidity will be obtained with each axillary temperature measurement
|
1-72 hours after birth
|
Seizure
Time Frame: Up to 4 weeks
|
Seizure activity diagnosed by medical director or nurse.
No electroencephalogram will be done.
|
Up to 4 weeks
|
Necrotizing enterocolitis or intestinal perforation
Time Frame: Up to 4 weeks
|
Documentation of pneumatosis or intestinal perforation on x-ray or treatment course for clinical necrotizing enterocolitis per Bell's Classification stage greater than 1.
|
Up to 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2013
Primary Completion (Anticipated)
October 1, 2018
Study Completion (Anticipated)
October 1, 2019
Study Registration Dates
First Submitted
May 21, 2012
First Submitted That Met QC Criteria
May 21, 2012
First Posted (Estimate)
May 23, 2012
Study Record Updates
Last Update Posted (Actual)
February 20, 2019
Last Update Submitted That Met QC Criteria
February 18, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UAB Neo 007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypothermia
-
RECIO PÉREZ, JESÚSUniversity of AlcalaCompletedHypothermia; Anesthesia | Hypothermia Following Anesthesia | Hypothermia Following Anesthesia, Sequela | Hypothermia Due to AnestheticSpain
-
The University of Texas Health Science Center,...RecruitingHypothermia; Anesthesia | Hypothermia, Newborn | Hypothermia, SequelaUnited States
-
Michael Garron HospitalCompletedHypothermia | Body Temperature Changes | Hypothermia Following Anesthesia | Hypothermia, Accidental | Hypothermia Due to AnestheticCanada
-
Centre Leon BerardCompletedHypothermia | Hypothermia; Anesthesia | Hypothermia, AccidentalFrance
-
Marmara UniversityCompletedHypothermia; Anesthesia | Hypothermia Following AnesthesiaTurkey
-
Marmara UniversityCompletedHypothermia; Anesthesia | Hypothermia Following AnesthesiaTurkey
-
Ciusss de L'Est de l'Île de MontréalCompletedHypothermia Following Anesthesia | Hypothermia, AccidentalCanada
-
Ankara Diskapi Training and Research HospitalCompletedPreventing Hypothermia | Perioperative HypothermiaTurkey
-
Universitat Internacional de CatalunyaRecruitingHypothermia | Hypothermia; Anesthesia | Hypothermia, AccidentalSpain
-
Universitair Ziekenhuis BrusselCompletedChildren | Hypothermia; Anesthesia | Hypothermia Following AnesthesiaBelgium
Clinical Trials on Thermoregulation-standard care
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
Instituto Mexicano del Seguro SocialCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaCompletedTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency ManagementUnited States
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia